Mindesta Inc (MDST) 0.0425 $MDST
Dr. Stephen Houldsworth, Pharma-Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board
ACCESSWIRE - Thu Jan 29, 8:52AM CST
Ottawa, ON / ACCESSWIRE / January 29, 2015 / The Board of Directors of Mindesta, Inc. (OTCBB:MDST) is pleased to announce the appointment of Dr. Stephen Houldsworth to it's advisory board of CTT Pharmaceuticals effective immediately:
Michelle Hamilton-Page Announced as eHealth SME Board Member
ACCESSWIRE - Wed Nov 26, 3:14PM CST
Toronto, Ontario / ACCESSWIRE / November 26, 2014 / The Board of Directors of Mindesta, Inc (OTC: MDST) is pleased to announce the appointment of Michelle Hamilton-Page, Digital Strategist, to the advisory board of CTT Pharmaceuticals effective immediately.
CTT announces eHealth SME advisory board member Michelle Hamilton-Page
ACCESSWIRE - Wed Nov 26, 10:22AM CST
Toronto, Ontario / ACCESSWIRE / November 26, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Michelle Hamilton-Page, Digital Strategist, to the advisory board of CTT Pharmaceuticals effective immediately.
Graham Wong, Marketing & Brand Entrepreneur, Joins CTT Management Team as Vice President, Marketing
ACCESSWIRE - Fri Nov 21, 8:24AM CST
Toronto, Ontario / ACCESSWIRE / November 21, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Graham Wong to Vice President, Marketing of CTT Pharmaceuticals management team.
CTT Expands Management Team Appointing Lucie Letellier to Chief Financial Officer
ACCESSWIRE - Thu Nov 06, 10:54AM CST
Toronto, Ontario / ACCESSWIRE / November 6, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Lucie Lettellier to Chief Financial Officer (CFO) of CTT Pharmaceuticals, effective immediately.
PZG: 1.49 (+0.02)
CTT Announces the Appointment of Steve Abboud, SME Medicinal Marijuana to Advisory Board
ACCESSWIRE - Wed Oct 29, 8:04AM CDT
Toronto, Ontario / ACCESSWIRE / October 29, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Steve Abboud to the Advisory Board of CTT Pharmaceuticals, effective immediately.
Gilles Derome, Dr. Dana Allen, Joins CTT Pharmaceuticals Advisory Board
ACCESSWIRE - Wed Oct 01, 8:08AM CDT
Toronto, Ontario / ACCESSWIRE / October 1, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) today announced the appointment of Gilles Derome and Dr. Dana Allen as Advisory Board members of the firm - CTT Pharmaceuticals, effective immediately.
Mindesta Announces Acquisition of CTT Pharmaceuticals, Inc.
Marketwire - Wed Sep 17, 8:04AM CDT
Mindesta Inc. ("Mindesta" or the "Company"
(OTCBB: MDST) has closed on its acquisition of of CTT Pharmaceuticals, Inc. ("CTT Pharma" , The Company, CTT Pharma and the shareholders of CTT Pharma executed a share exchange agreement which provide in part for the Company to acquire all the issued and outstanding shares of common stock of CTT Pharma in exchange for 149,183,285 shares of the Company's common stock. With the acquisition of CTT Pharma, the Company has 184,368,022 shares of common stock issued and outstanding. CTT Pharma will operate as a subsidiary of Mindesta.
Dr. Stephen Houldsworth, Pharma-Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board
ACCESSWIRE - Thu Jan 29, 8:52AM CST
Ottawa, ON / ACCESSWIRE / January 29, 2015 / The Board of Directors of Mindesta, Inc. (OTCBB:MDST) is pleased to announce the appointment of Dr. Stephen Houldsworth to it's advisory board of CTT Pharmaceuticals effective immediately:
Michelle Hamilton-Page Announced as eHealth SME Board Member
ACCESSWIRE - Wed Nov 26, 3:14PM CST
Toronto, Ontario / ACCESSWIRE / November 26, 2014 / The Board of Directors of Mindesta, Inc (OTC: MDST) is pleased to announce the appointment of Michelle Hamilton-Page, Digital Strategist, to the advisory board of CTT Pharmaceuticals effective immediately.
CTT announces eHealth SME advisory board member Michelle Hamilton-Page
ACCESSWIRE - Wed Nov 26, 10:22AM CST
Toronto, Ontario / ACCESSWIRE / November 26, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Michelle Hamilton-Page, Digital Strategist, to the advisory board of CTT Pharmaceuticals effective immediately.
Graham Wong, Marketing & Brand Entrepreneur, Joins CTT Management Team as Vice President, Marketing
ACCESSWIRE - Fri Nov 21, 8:24AM CST
Toronto, Ontario / ACCESSWIRE / November 21, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Graham Wong to Vice President, Marketing of CTT Pharmaceuticals management team.
CTT Expands Management Team Appointing Lucie Letellier to Chief Financial Officer
ACCESSWIRE - Thu Nov 06, 10:54AM CST
Toronto, Ontario / ACCESSWIRE / November 6, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Lucie Lettellier to Chief Financial Officer (CFO) of CTT Pharmaceuticals, effective immediately.
PZG: 1.49 (+0.02)
CTT Announces the Appointment of Steve Abboud, SME Medicinal Marijuana to Advisory Board
ACCESSWIRE - Wed Oct 29, 8:04AM CDT
Toronto, Ontario / ACCESSWIRE / October 29, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) is pleased to announce the appointment of Steve Abboud to the Advisory Board of CTT Pharmaceuticals, effective immediately.
Gilles Derome, Dr. Dana Allen, Joins CTT Pharmaceuticals Advisory Board
ACCESSWIRE - Wed Oct 01, 8:08AM CDT
Toronto, Ontario / ACCESSWIRE / October 1, 2014 / The Board of Directors of Mindesta, Inc (OTCBB: MDST) today announced the appointment of Gilles Derome and Dr. Dana Allen as Advisory Board members of the firm - CTT Pharmaceuticals, effective immediately.
Mindesta Announces Acquisition of CTT Pharmaceuticals, Inc.
Marketwire - Wed Sep 17, 8:04AM CDT
Mindesta Inc. ("Mindesta" or the "Company"
(OTCBB: MDST) has closed on its acquisition of of CTT Pharmaceuticals, Inc. ("CTT Pharma" , The Company, CTT Pharma and the shareholders of CTT Pharma executed a share exchange agreement which provide in part for the Company to acquire all the issued and outstanding shares of common stock of CTT Pharma in exchange for 149,183,285 shares of the Company's common stock. With the acquisition of CTT Pharma, the Company has 184,368,022 shares of common stock issued and outstanding. CTT Pharma will operate as a subsidiary of Mindesta. 
